Cite
HARVARD Citation
Laustsen, A. et al. (2018). Pros and cons of different therapeutic antibody formats for recombinant antivenom development. Toxicon. pp. 151-175. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Laustsen, A. et al. (2018). Pros and cons of different therapeutic antibody formats for recombinant antivenom development. Toxicon. pp. 151-175. [Online].